PanCD44 Immunohistochemical Evaluation in Prostatectomies from Patients with Adenocarcinoma

INTRODUCTION: CD44 has been proposed as a prognostic marker and a stem cell marker but studies in patients with prostate cancer have yielded inconsistent results. PATIENTS AND METHODS: Patients submitted to radical prostatectomy between 2008 and 2013 at a university hospital were followed with biann...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirth, Carlos Gustavo, dos Santos, Adriele Machado, de Cerqueira, João Batista Gadelha, Jamacaru, Francisco Vagnaldo Fechine, da Cunha, Maria do Perpétuo Socorro Saldanha, Dornelas, Conceição Aparecida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846379/
https://www.ncbi.nlm.nih.gov/pubmed/29682524
http://dx.doi.org/10.1155/2018/2061268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846379/
https://www.ncbi.nlm.nih.gov/pubmed/29682524
http://dx.doi.org/10.1155/2018/2061268

Ejemplares similares